The Effect of Prophylactic Hemodialysis on the Morbidity and Mortality of the Patients With Chronic Kidney Disease Stages 3-4 Undergoing Coronary Artery Graft Bypass

A phase 2/3 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 120 participants.

Also called NCT01410617

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose prevention
Phase
Phase 2/3
Enrolled
  • 120 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT01410617
Start date
(registry gives no type) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Iran (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT01410617. Randomized; no masking; primary purpose prevention. Start 2011-08 (registry gives no type); primary completion 2013-09 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
The Effect of Prophylactic Hemodialysis on the Morbidity and Mortality of the Patients With Chronic Kidney Disease Stages 3-4 Undergoing Coronary Artery Graft Bypass
Condition
Chronic Kidney Disease stage3
Condition
Chronic Kidney Disease stage4
Intervention (Procedure)
hemodialysis
Lead sponsor
Imam Khomeini Hospital (class: other)
Collaborator
Tehran University of Medical Sciences (class: other)

Record details

Record id
cardio:ct-nct01410617
Content hash
a8b05ca30409c6762d82b46c47352e975311db4e1f1f906e9870c331cfaebac0